Real‐World Outcomes of Opti‐Hep‐D: An Innovative, Multicentre and Multidisciplinary Program Improving Hepatitis D Cascade of Care
Liver International · 2026-06 · 46 (6)
DOI: 10.1111/liv.70672 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift Liver International, online erschienen am 19.05.2026. Verfasst von Adriana Palom und 20 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain. Hauptthemen laut MEDLINE: Hepatitis D, Mass Screening. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Gilead Sciences.
Abstract (Originalsprache)
Background and Aim Hepatitis D virus (HDV) infection remains underdiagnosed, and real‐world data on screening and linkage to care are limited. We assessed the implementation of Opti‐Hep‐D, a publicly funded initiative for HDV management in the Spanish region of Catalonia.
Methods
In this prospective multicentre study conducted between January 2024 and April 2025, all HBsAg‐positive samples underwent reflex anti‐HDV and HDV‐RNA testing, with subsequent active linkage to care of individuals testing positive. Clinical data were collected in their electronic medical records. Patient characteristics, risk factors, and bulevirtide initiation wereanalysed.
Results
Of 369 581 HBsAg determinations, 6100 were positive. Anti‐HDV testing was completed in 5399 (89%), identifying 305 (5.6%) positive individuals. HDV‐RNA was assessed in 285 patients, of whom 86 (30%) were viremic. Among 2945 first‐time anti‐HDV tests, 130 (4.4%) were positive and 26 (20%) were viremic. Notably, 42% of positive patients had no documented risk factors or elevated ALT. HDV prevalence varied across settings (2.3%–14%) and was highest in prisons. Newly diagnosed individuals tended to be younger with milder disease. Among 86 viremic individuals, 95% were successfully linked to care and 43% initiated bulevirtide; 57% remained untreated due to patient‐related or reimbursement barriers. No prison inmates received bulevirtide, mainly because of complex social situations.
Conclusions
Large‐scale double reflex HDV screening with active linkage to care is feasible and effective in real‐world practice and may serve as a model for other healthcare settings. Although care engagement is high, treatment initiation remained limited by structural and social barriers.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Universitat Autònoma de Barcelona, Barcelona, Spain.
- Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas, Madrid, Spain.
- Microbiology Department, Hospital Universitari Vall d'Hebron, Barcelona, Spain.
- Microbiology Department, Hospital Universitari de Bellvitge, Barcelona, Spain.
- Microbiology Department, Clinical Laboratory North Metropolitan Area, Hospital Universitari Germans Trias I Pujol, Badalona, Spain.
- Microbiology Department, Hospital Universitari Joan XXIII De Tarragona, Tarragona, Spain.
ORCID-Profile: Joana Villaverde, Indiana Abdo
Förderung
- Gilead Sciences
Zitieren
APA
Palom, A., Rando-Segura, A., Calatayud-Samper, L., Fernández-Rivas, G., Sellés-Sanchez, A., Mormeneo-Bayo, S., Del Campo, D. P., Del Corral, E., Balari, T., Morillas, R. M., Rodríguez-Castellano, A., Huelin, P., Lopez, C., Salazar, D., Villaverde, J., Abdo, I., Castellote, J., Boniquet, J. C. Q., Blanch, C. A., …, & Buti, M. (2026). Real‐World Outcomes of Opti‐Hep‐D: An Innovative, Multicentre and Multidisciplinary Program Improving Hepatitis D Cascade of Care. Liver International, 46(6). https://doi.org/10.1111/liv.70672
Vancouver
Palom A, Rando-Segura A, Calatayud-Samper L, Fernández-Rivas G, Sellés-Sanchez A, Mormeneo-Bayo S, et al. Real‐World Outcomes of Opti‐Hep‐D: An Innovative, Multicentre and Multidisciplinary Program Improving Hepatitis D Cascade of Care. Liver International. 2026;46(6). doi:10.1111/liv.70672
BibTeX
@article{Palom2026,
author = {Palom, Adriana and Rando-Segura, Ariadna and Calatayud-Samper, Laura and Fernández-Rivas, Gema and Sellés-Sanchez, Alicia and Mormeneo-Bayo, Saray and Del Campo, Dúnia Pérez and Del Corral, Eva and Balari, Tomàs and Morillas, Rosa Maria and Rodríguez-Castellano, Adrià and Huelin, Patricia and Lopez, Carmen and Salazar, Darly and Villaverde, Joana and Abdo, Indiana and Castellote, José and Boniquet, Joan Carles Quer and Blanch, Carles Aracil and Marco, Andrés and Buti, Maria},
title = {Real‐World Outcomes of Opti‐Hep‐D: An Innovative, Multicentre and Multidisciplinary Program Improving Hepatitis D Cascade of Care},
journal = {Liver International},
year = {2026},
volume = {46},
number = {6},
doi = {10.1111/liv.70672}
}
EUVIMED